Dayvigo
Brand Name: Dayvigo
Generic Name: Lemborexant
Active
Registration Number
DR-XY47690
Dosage Form
Film-Coated Tablet
Issuance Date
January 28, 2022
Expiry Date
January 28, 2027
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength5mg
PackagingAlu/PVC Blister Pack x 14's (Box of 28's)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Orexin Receptor Antagonist
A
Application
Monitored Release
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
LemborexantActive
Monograph: Lemborexant